Zofenopril
- Generic Name
- Zofenopril
- Drug Type
- Small Molecule
- Chemical Formula
- C22H23NO4S2
- CAS Number
- 81872-10-8
- Unique Ingredient Identifier
- 290ZY759PI
- Background
Zofenopril is employed as both a cardioprotective and anti-hypertensive agent. It is an angiotensin-converting enzyme (ACE) inhibitor.
- Indication
用于治疗原发性高血压、肾性该血压、心力衰竭。
- Associated Conditions
- Acute Myocardial Infarction (AMI), Hypertension, Mild to Moderate Hypertension
Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Menarini International Operations Luxembourg SA
- Target Recruit Count
- 277
- Registration Number
- NCT05279807
- Locations
- 🇭🇺
Investigational site, Debrecen, Hungary
Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2022-02-28
- Lead Sponsor
- Menarini International Operations Luxembourg SA
- Target Recruit Count
- 296
- Registration Number
- NCT05257148
- Locations
- 🇮🇹
Istituto Clinico Humanitas, Milano, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath